101 related articles for article (PubMed ID: 21385124)
1. Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents.
Antonelli A; Sfara C; Manuali E; Bruce IJ; Magnani M
Nanomedicine (Lond); 2011 Feb; 6(2):211-23. PubMed ID: 21385124
[TBL] [Abstract][Full Text] [Related]
2. New strategies to prolong the in vivo life span of iron-based contrast agents for MRI.
Antonelli A; Sfara C; Battistelli S; Canonico B; Arcangeletti M; Manuali E; Salamida S; Papa S; Magnani M
PLoS One; 2013; 8(10):e78542. PubMed ID: 24223101
[TBL] [Abstract][Full Text] [Related]
3. Red blood cells as carriers in magnetic particle imaging.
Antonelli A; Sfara C; Rahmer J; Gleich B; Borgert J; Magnani M
Biomed Tech (Berl); 2013 Dec; 58(6):517-25. PubMed ID: 23839809
[TBL] [Abstract][Full Text] [Related]
4. Ferucarbotran-loaded red blood cells as long circulating MRI contrast agents: first in vivo results in mice.
Antonelli A; Pacifico S; Sfara C; Tamma M; Magnani M
Nanomedicine (Lond); 2018 Apr; 13(7):675-687. PubMed ID: 29488423
[TBL] [Abstract][Full Text] [Related]
5. Development of long circulating magnetic particle imaging tracers: use of novel magnetic nanoparticles and entrapment into human erythrocytes.
Antonelli A; Szwargulski P; Scarpa ES; Thieben F; Cordula G; Ambrosi G; Guidi L; Ludewig P; Knopp T; Magnani M
Nanomedicine (Lond); 2020 Apr; 15(8):739-753. PubMed ID: 32207374
[No Abstract] [Full Text] [Related]
6. USPIO-loaded red blood cells as a biomimetic MR contrast agent: a relaxometric study.
Boni A; Ceratti D; Antonelli A; Sfara C; Magnani M; Manuali E; Salamida S; Gozzi A; Bifone A
Contrast Media Mol Imaging; 2014; 9(3):229-36. PubMed ID: 24700750
[TBL] [Abstract][Full Text] [Related]
7. Rapid microwave-assisted synthesis of dextran-coated iron oxide nanoparticles for magnetic resonance imaging.
Osborne EA; Atkins TM; Gilbert DA; Kauzlarich SM; Liu K; Louie AY
Nanotechnology; 2012 Jun; 23(21):215602. PubMed ID: 22551699
[TBL] [Abstract][Full Text] [Related]
8. [Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T].
Ittrich H; Lange C; Dahnke H; Zander AR; Adam G; Nolte-Ernsting C
Rofo; 2005 Aug; 177(8):1151-63. PubMed ID: 16021549
[TBL] [Abstract][Full Text] [Related]
9. New biomimetic constructs for improved in vivo circulation of superparamagnetic nanoparticles.
Antonelli A; Sfara C; Mosca L; Manuali E; Magnani M
J Nanosci Nanotechnol; 2008 May; 8(5):2270-8. PubMed ID: 18572637
[TBL] [Abstract][Full Text] [Related]
10. Optimization of magnetic nanoparticles for engineering erythrocytes as theranostic agents.
Slavu LM; Antonelli A; Scarpa ES; Abdalla P; Wilhelm C; Silvestri N; Pellegrino T; Scheffler K; Magnani M; Rinaldi R; Di Corato R
Biomater Sci; 2023 May; 11(9):3252-3268. PubMed ID: 36939172
[TBL] [Abstract][Full Text] [Related]
11. Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxide.
Alam SR; Stirrat C; Richards J; Mirsadraee S; Semple SI; Tse G; Henriksen P; Newby DE
J Cardiovasc Magn Reson; 2015 Sep; 17(1):83. PubMed ID: 26381872
[TBL] [Abstract][Full Text] [Related]
12. MRI contrast enhancement potential of different superparamagnetic iron oxide nanoparticle (SPION) formulations.
Schweiger C; Gil P; Parak W; Kissel T
J Control Release; 2010 Nov; 148(1):e67-8. PubMed ID: 21529634
[No Abstract] [Full Text] [Related]
13. Characterization of ferucarbotran-loaded RBCs as long circulating magnetic contrast agents.
Antonelli A; Sfara C; Weber O; Pison U; Manuali E; Salamida S; Magnani M
Nanomedicine (Lond); 2016 Nov; 11(21):2781-2795. PubMed ID: 27739933
[TBL] [Abstract][Full Text] [Related]
14. The effect of poly(ethylene glycol) coating on colloidal stability of superparamagnetic iron oxide nanoparticles as potential MRI contrast agent.
Masoudi A; Madaah Hosseini HR; Shokrgozar MA; Ahmadi R; Oghabian MA
Int J Pharm; 2012 Aug; 433(1-2):129-41. PubMed ID: 22579990
[TBL] [Abstract][Full Text] [Related]
15. SHU 555A. A new superparamagnetic iron oxide contrast agent for magnetic resonance imaging.
Hamm B; Staks T; Taupitz M
Invest Radiol; 1994 Jun; 29 Suppl 2():S87-9. PubMed ID: 7928280
[No Abstract] [Full Text] [Related]
16. The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages.
Lunov O; Syrovets T; Büchele B; Jiang X; Röcker C; Tron K; Nienhaus GU; Walther P; Mailänder V; Landfester K; Simmet T
Biomaterials; 2010 Jul; 31(19):5063-71. PubMed ID: 20381862
[TBL] [Abstract][Full Text] [Related]
17. Heparin-coated superparamagnetic iron oxide for in vivo MR imaging of human MSCs.
Lee JH; Jung MJ; Hwang YH; Lee YJ; Lee S; Lee DY; Shin H
Biomaterials; 2012 Jun; 33(19):4861-71. PubMed ID: 22475532
[TBL] [Abstract][Full Text] [Related]
18. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging.
Arbab AS; Bashaw LA; Miller BR; Jordan EK; Lewis BK; Kalish H; Frank JA
Radiology; 2003 Dec; 229(3):838-46. PubMed ID: 14657318
[TBL] [Abstract][Full Text] [Related]
19. Magnetoliposomes as magnetic resonance imaging contrast agents.
Soenen SJ; Velde GV; Ketkar-Atre A; Himmelreich U; De Cuyper M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(2):197-211. PubMed ID: 25363747
[TBL] [Abstract][Full Text] [Related]
20. Electrosprayed synthesis of red-blood-cell-like particles with dual modality for magnetic resonance and fluorescence imaging.
Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T
Small; 2010 Nov; 6(21):2384-91. PubMed ID: 20878793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
